These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23492463)

  • 1. Ranolazine-induced myopathy in a patient on chronic statin therapy.
    Correa D; Landau M
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):114-6. PubMed ID: 23492463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proximal myopathy secondary to statin treatment in a patient with Hashimoto thyroiditis].
    Ferreiro JL; Dapena Mdel C; Suárez RL; Pérez-Argüelles BS; Vázquez CM
    Endocrinol Nutr; 2009; 56(7):387. PubMed ID: 19883901
    [No Abstract]   [Full Text] [Related]  

  • 3. Myopathy during treatment with the antianginal drug ranolazine.
    Kassardjian CD; Tian X; Vladutiu G; Wong LJ; Milone M
    J Neurol Sci; 2014 Dec; 347(1-2):380-2. PubMed ID: 25466697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyolysis in a patient receiving ranolazine and simvastatin.
    Hylton AC; Ezekiel TO
    Am J Health Syst Pharm; 2010 Nov; 67(21):1829-31. PubMed ID: 20966146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.
    Abdelbaset M; Safar MM; Mahmoud SS; Negm SA; Agha AM
    Can J Physiol Pharmacol; 2014 Jun; 92(6):481-9. PubMed ID: 24896301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle symptoms associated with statins: a series of twenty patients.
    Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-induced, immune-mediated necrotising myopathy triggered by malignancy successfully treated with immunosuppression.
    Abouelazm A; Philops K; Amine A; Golam Y
    Clin Med (Lond); 2024 May; 24(3):100217. PubMed ID: 38710328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STOMPing forward: statins, muscle complaints and CK.
    Laaksonen R
    Atherosclerosis; 2013 Oct; 230(2):256-7. PubMed ID: 24075753
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of high-dose atorvastatin therapy.
    Waters DD
    Am J Cardiol; 2005 Sep; 96(5A):69F-75F. PubMed ID: 16126026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.
    Molden E; Skovlund E; Braathen P
    Drug Saf; 2008; 31(7):587-96. PubMed ID: 18558792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-associated myopathy with normal creatine kinase levels.
    Phillips PS; Haas RH; Bannykh S; Hathaway S; Gray NL; Kimura BJ; Vladutiu GD; England JD;
    Ann Intern Med; 2002 Oct; 137(7):581-5. PubMed ID: 12353945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive myopathy with up-regulation of MHC-I associated with statin therapy.
    Needham M; Fabian V; Knezevic W; Panegyres P; Zilko P; Mastaglia FL
    Neuromuscul Disord; 2007 Feb; 17(2):194-200. PubMed ID: 17241784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin for stroke prevention.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statin-induced dysphagia].
    Edholm B
    Ugeskr Laeger; 2010 Feb; 172(7):544-5. PubMed ID: 20156405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranolazine: a novel therapeutic option in chronic stable angina.
    Jose J; Jimmy B; Saravu K; Shastry BA
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):596-9. PubMed ID: 18604102
    [No Abstract]   [Full Text] [Related]  

  • 17. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.
    Laaksonen R; Katajamaa M; Päivä H; Sysi-Aho M; Saarinen L; Junni P; Lütjohann D; Smet J; Van Coster R; Seppänen-Laakso T; Lehtimäki T; Soini J; Oresic M
    PLoS One; 2006 Dec; 1(1):e97. PubMed ID: 17183729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy.
    Bogsrud MP; Langslet G; Ose L; Arnesen KE; Sm Stuen MC; Malt UF; Woldseth B; Retterstøl K
    Scand Cardiovasc J; 2013 Apr; 47(2):80-7. PubMed ID: 23301875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A benign tumor as the apparent trigger for myopathy.
    Durcan L; Gleeson N; McKiernan S; Cunnane G
    J Clin Rheumatol; 2014 Mar; 20(2):115-7. PubMed ID: 24561420
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased dosage of cyclosporine induces myopathy with increased seru creatine kinase in an elderly patient on chronic statin therapy.
    Mo L; He J; Yue Q; Dong B; Huang X
    J Clin Pharm Ther; 2015 Apr; 40(2):245-8. PubMed ID: 25512016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.